| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating | 
|---|
																	UBS analyst Danielle Antalffy maintains DexCom (NASDAQ:DXCM) with a Buy and lowers the price target from $106 to $95.
																	Truist Securities analyst Richard Newitter reiterates DexCom (NASDAQ:DXCM) with a Buy and lowers the price target from $94 t...
																	Barclays analyst Matt Miksic maintains DexCom (NASDAQ:DXCM) with a Equal-Weight and lowers the price target from $98 to $80.
																	These ten large-cap stocks led last week's declines, including Fiserv, Alexandria Real Estate, Chipotle, eBay, after weak r...
																	Wells Fargo analyst Larry Biegelsen maintains DexCom (NASDAQ:DXCM) with a Overweight and lowers the price target from $98 to...
																	Canaccord Genuity analyst William Plovanic maintains DexCom (NASDAQ:DXCM) with a Buy and lowers the price target from $106 t...
																	Citigroup analyst Joanne Wuensch maintains DexCom (NASDAQ:DXCM) with a Buy and lowers the price target from $85 to $75.
																	JP Morgan analyst Robbie Marcus maintains DexCom (NASDAQ:DXCM) with a Neutral and lowers the price target from $90 to $75.
																	TD Cowen analyst Joshua Jennings maintains DexCom (NASDAQ:DXCM) with a Buy and lowers the price target from $100 to $84.